INMD News and Press, InMode Ltd. From 06/25/22

InMode (NASDAQ: INMD) is proof that there isn't always a trade-off between stocks with great value and those with tremendous growth potential. This medical device maker has everything you'd expect from a value stock -- a low valuation, repeatable business model, and cost-sensitive m...

InMode (NASDAQ:INMD) launched EmpowerRF device for women wellness in Canada. The company said it recently received Health Canada certification to improve urinary incontinence symptoms, adding to previous licenses for improving the symptoms of Genitourinary Syndrome of menopause, chronic ...

InMode Receives Health Canada Certification of EmpowerRF Women's Wellness Technology PR Newswire IRVINE, Calif. , June 15, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is proud to anno...

There are few things as sweet as a 10-bagger stock that you've watched grow and grow. Investors only need a couple of home runs to make up for the lemons in their portfolio, and that's why it's crucial to find stocks that have a shot to 10X. With growth of 267.4% in the last three years...

I provide a brief background of InMode and its company's operations, and also the recent sell-off of InMode stock. I explain why investing in InMode could be a good decision at its current valuation by analyzing the company's prospects and historical financial performance. I concl...

Gainers: Elevation Oncology (ELEV) +9%. INMODE  (INMD) +6%. Inspirato Incorporated (ISPO) +5%. Ranger Oil Corporation (ROCC) +5%. Anavex Life Sciences  (AVXL) +5%. Losers: Concert Pharmaceuticals (CNCE) -17%. Chindata Group Holdings Limited (CD) -11%. Conn's (CONN) -7%. Am...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: iQoncept / Shutterstock.com Markets often misprice stocks. Its pricing inefficiency creates opportunities for investors who spot the discount or premium before anyone else does. In the retail sector, companies t...

InMode had double-digit revenue and net income growth year-over-year. Gross margin remains above 80%, despite the negative impact of the increased shipping costs. The firm announced a share buyback program up to 1 million shares. InMode appears undervalued based on traditional...

InMode to Participate at the UBS Healthcare One-on-One Virtual Day PR Newswire YOKNEAM, Israel , May 23, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) , a leading global provider of innovative medical technologies, today announced that Moshe Miz...

Below I explain why InMode has sold off so aggressively since the start of 2022. With $400M of cash on hand, management could repurchase 25% of their float based on InMode's current valuation. NTM EV/EBITDA already sits at 7.4x with what looks like more downside to go. For f...